Search hospitals > Florida > Pensacola
Sacred Heart Hospital
Claim this profilePensacola, Florida 32504
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
129 reported clinical trials
8 medical researchers
Summary
Sacred Heart Hospital is a medical facility located in Pensacola, Florida. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Lung Cancer, Tumors and other specialties. Sacred Heart Hospital is involved with conducting 129 clinical trials across 283 conditions. There are 8 research doctors associated with this hospital, such as Erlyn C. Smith, Ranjith B. Dissanayake, Rohit Amin, MD, and Dany El-Sayah.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Leukemia
Global LeaderBCR-ABL1 fusion positive
ABL-class fusion positive
13q positive
Top PIs
Erlyn C. SmithSacred Heart Hospital4 years of reported clinical research
Studies Tumors
Studies Leukemia
29 reported clinical trials
80 drugs studied
Ranjith B. DissanayakeSacred Heart Hospital1 year of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
8 drugs studied
Rohit Amin, MDAscension Sacred Heart1 year of reported clinical research
Studies Heart Failure
Studies Iron Deficiency
7 reported clinical trials
10 drugs studied
Dany El-SayahSacred Heart Hospital7 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
3 reported clinical trials
6 drugs studied
Clinical Trials running at Sacred Heart Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Heart Failure
Lung Cancer
Osteosarcoma
Germ Cell Tumors
Lymphoma
Brain Tumor
Rhabdomyosarcoma
Ovarian Tumors
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sacred Heart Hospital?
Sacred Heart Hospital is a medical facility located in Pensacola, Florida. This center is recognized for care of Cancer, Leukemia, Breast Cancer, Lung Cancer, Tumors and other specialties. Sacred Heart Hospital is involved with conducting 129 clinical trials across 283 conditions. There are 8 research doctors associated with this hospital, such as Erlyn C. Smith, Ranjith B. Dissanayake, Rohit Amin, MD, and Dany El-Sayah.